A DOUBLE-BLIND, RANDOMLY CONTROLLED PLACEBO STUDY TO EVALUATE THE RENAL PROTECTIVE EFFECTS OF LOSARTAN IN PATIENTS WITH DIABETES MELLITUS NON-INSULIN DEPENDENTS AND NEPHROPATHY

MERCK SHARP & DOHME PERU S.R.L.,0 个研究点目标入组 0 人开始时间: 2000年9月21日最近更新: 2023年9月4日

适应症

试验速览

暂无简介。

研究类型: Interventional
分配方式: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

•- Diabetes diagnosed after the age of 30
•- Insulin not required within 6 months of first being diagnosed with Non-insulin
•Dependent Diabetes Mellitus
•- No history of diabetic ketoacidosis
•- Patients may be currently treated with diet, oral hypoglycemics or insulin
•- Patients must have proteinuria defined as: Urine protein >1+ on dipstick at the
•initial screening visit
•- Patients with hypertension (high blood pressure) must have a sitting blood pressure
•>200/110 mm Hg at Visit 1

•- Patients with insulin-dependent diabetes mellitus (juvenile onset)
•- Patients treated with an ACE inhibitor or angiotensin II antagonist (AIIA) for >5
•- Patients treated with ACE inhibitor or AIIA therapy for 5 years or less may enter the
•study provided therapy is discontinued during the 6 week screening period prior to
•randomization
•- History of myocardial infarction (MI) (heart attack) or coronary artery bypass graft
•(CABG) surgery within the past 1 month
•- History of cerebral vascular accident (CVA) (stroke) or percutaneous transluminal
•coronary angioplasty (PTCA) within the past 6 months
•- History of transient ischemic attacks (TIA) within the past year. Patients with
•unstable angina are excluded until stabilized
•- Heart failure requiring ACE inhibitor therapy
•- Steroids (oral or parenteral) or immunosuppressives are not permitted. Debilitating
•psychological illness
•- Evidence of significant hepatic (liver) dysfunction: History of allergy to losartan
•- Known positive test for HIV or patients known to be hepatitis B or C antigen carriers
•- Pregnant or nursing women
•- Females of childbearing age must either be surgically sterilized or, if sexually
•active, using an effective form of contraception and may enter only if an
•exclusionary pregnancy test is done within approximately 72 hours prior to
•randomization
•- Pregnancy tests will be done every 3 months during the study and at the time of
•discontinuation

发起方

MERCK SHARP & DOHME PERU S.R.L.,